Galmed Pharmaceuticals (GLMD) Cost of Revenue (2022 - 2023)
Galmed Pharmaceuticals (GLMD) recorded quarterly Cost of Revenue of $200000.0 in Q1 2023, up 300.0% quarter-over-quarter from $50000.0 in Q1 2022, and up 300.0% on a YoY basis from $50000.0 in Q1 2022.
Galmed Pharmaceuticals (GLMD) Cost of Revenue (2022 - 2023) Analysis & Trends
Galmed Pharmaceuticals' Cost of Revenue history runs 2 years deep, the most recent figure standing at $200000.0 for Q1 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 64.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 48,670.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 392.80 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 2.05 Mn |
| 10 | Galmed Pharmaceuticals | 2.48 Mn | -1.63 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | 200,000.00 |
| Mar 31, 2023 | 200,000.00 |
| Mar 31, 2022 | 50,000.00 |
| Mar 31, 2022 | 50,000.00 |